Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
The Company will participate in the Q3 FY24 Conference Call (i.e. Post Earnings/Quarterly Call), as organized by YES Securities (India) Ltd. on Monday, February 05, 2024 at 9:00 a.m. (IST) to discuss the financial results of the Company for the quarter and nine months ended December 31, 2023. Metropolis Healthcare Ltd - 542650 - Board Meeting Intimation for Consideration And Approval Of Unaudited Standalone & Consolidated Financial Results Of The Company For The Quarter And Nine Months Ended December 31, 2023.
Metropolis Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/02/2024 ,inter alia, to consider and approve Unaudited Standalone & Consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2023. Metropolis Healthcare Ltd - 542650 - Intimation Regarding Shift Of Registered Office Of The Company Within The Local Limits.
The Board of Directors of the Company vide Resolution passed by Circulation dated January 17, 2024 have accorded their consent to Shift the Registered Office of the Company from "250 D Udyog Bhavan Worli, Mumbai, Maharashtra, India, 400030" to "4th floor, East Wing, Nirlon House, Dr. Annie Besant Road, Worli, Mumbai 400018, Maharashta, India" Metropolis Healthcare Ltd - 542650 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
We herewith enclose the certificate issued by M/s. Link Intime India Private Limited, Registrar and Transfer Agent of the Company confirming the compliance of Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended December 31, 2023.
Metropolis Healthcare Clarifies Stand On Alleged Mohalla Clinics Corruption
The billing for testing has been strictly done on the basis of the sample received, test performed, and reported, the company said. Metropolis Healthcare Ltd - 542650 - Metropolis Healthcare Limited Has Informed The Exchange Regarding A Statement Addressing Recent Media Reports Concerning The "Aam Aadmi Mohalla Clinic Project."
The Company has provided statement in the matter of "Aam Aadmi Mohalla Clinic project." Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
This is to inform you that, Nomination and Remuneration Committee of the Board of Directors of the Company via circular resolution dated January 13, 2024 have approved the allotment of 3,267 Equity shares of Rs. 2/- each aggregating to Rs. 6,534/- against the Restrictive Stock Units vested in and exercised by the employees of the Company under the MHL-Restrictive Stock Unit Plan, 2020. Metropolis Healthcare Ltd - 542650 - Business Updates For 3Rd Quarter Ended December 31, 2023.
In accordance with the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015, Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information and Regulation 8 of the SEBI (Prohibition of Insider Trading) Regulations, 2015, the Company has provided a business update for the quarter ended December 31, 2023. Metropolis Healthcare Ltd - 542650 - Closure of Trading Window
This is to inform you that the Trading Window will be closed for dealing in securities of the Company by the Designated Persons of the Company from January 1, 2024 and shall remain closed up to 48 hours after declaration of the Financial Results for the Quarter ending December 31, 2023. Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
This is to inform you that the officials of the company will be meeting Investors/ Analysts (Participants) as per the date mentioned below: 1. 06th -07th December 2023, Place- Singapore 2. 08th December 2023, Place - HongKong. Further the mode of this meetings will be In- Person (Non-deal Roadshow) and Nuvama Institutional Equities will be the host.